Cite
HARVARD Citation
Kavan, P. et al. (n.d.). 494PA multi-institutional randomized phase II study on the timing of oxaliplatin plus 5-fluorouracil (FOLFOX) for patients (pts) with operable stage III rectal cancer: The KIR study. Annals of oncology. p. . [Online].